NewSelf Review
Industry-low flat-dose pricing on compounded semaglutide and tirzepatide — all dosages, one price, no membership fee.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Quick Verdict
One of the most aggressively priced compounded GLP-1 clinics on the market. Flat-dose pricing is a genuine differentiator — you won't pay more as your dose increases. Customer service responsiveness has been flagged in some reviews; verify support quality before committing to a long-term plan.
- Industry-low pricing — semaglutide from $99.97/mo
- Flat-dose pricing: all dosages cost the same
- No membership or subscription fee
- 3-month supply upfront eliminates refill delays
- 1,000+ board-certified physicians across all 50 states
- Overnight shipping available
- Customer service responsiveness flagged in some reviews
- Compounded only — no brand-name GLP-1 access
- Some billing confusion reported on multi-month plans
- Limited coaching or behavioral support
NewSelf Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at NewSelf.
| Program / Membership Fee | No membership fee |
| Medication Cost (From) | From $99 – $224/mo |
NewSelf uses flat-dose pricing — all dosage levels cost the same monthly rate. Compounded semaglutide starts at $99.97/mo and tirzepatide at $144.49/mo (promotional pricing). No membership or subscription fee. 3-month supply shipped upfront. Annual plans available from $194.97/mo.
Who NewSelf Is For
NewSelf is best for budget-focused adults who want the lowest possible monthly cost on compounded GLP-1 and don't want to pay more as their dose escalates. The 3-month upfront supply eliminates refill delays. Not ideal for patients who want live provider consults or extensive coaching support.
Budget-conscious adults seeking compounded GLP-1 with transparent flat-dose pricing and no membership fees.
Signature Programs
- ›Compounded semaglutide with B12 (all doses, same price)
- ›Compounded tirzepatide with B6 (all doses, same price)
- ›3-month supply upfront — no refill delays
Medication Formulary
How NewSelf Scores
NewSelf scores 4.6 / 5 overall (cost 4.8, experience 4.2, trust 4.3), which makes it one of the top-tier options in the GLP-1 weight loss category we cover.
See how NewSelf compares in our full GLP-1 weight loss rankings, or read the Best Compounded GLP-1 Telehealth Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
How much does NewSelf cost per month?
NewSelf's published pricing runs $99 to $224 per month. NewSelf uses flat-dose pricing — all dosage levels cost the same monthly rate. Compounded semaglutide starts at $99.97/mo and tirzepatide at $144.49/mo (promotional pricing). No membership or subscription fee. 3-month supply shipped upfront. Annual plans available from $194.97/mo. Confirm the all-in monthly total at checkout, because telehealth pricing changes without notice.
What medications does NewSelf prescribe?
NewSelf lists compounded semaglutide, compounded tirzepatide. It focuses on compounded medications rather than FDA-approved brand-name drugs. What you are prescribed depends on the clinician's assessment and your state.
Is NewSelf legit?
NewSelf connects patients with licensed clinicians for GLP-1 weight loss care. At our last check it held a 4.5/5 Trustpilot rating from 3,259 reviews. We score its trust and transparency at 4.3/5. Before ordering, check that the clinician is licensed in your state and, for compounded drugs, which pharmacy fills the prescription.
Can I cancel NewSelf anytime?
Most telehealth plans, NewSelf's included, are cancelled through the patient portal or support team, but refund terms vary. Compounded medication is made to order, so shipments are usually non-refundable once dispensed. Read the current terms before your first refill date to avoid an unwanted renewal.
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
